|
Baroja-Mazo A, Martín-Sánchez F, Gomez AI, Martínez CM, Amores-Iniesta J, Compan V, Barberà-Cremades M, Yagüe J, Ruiz-Ortiz E, Antón J, Buján S, Couillin I, Brough D, Arostegui JI, Pelegrín P. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014 Aug;15(8):738-48. doi: 10.1038/ni.2919. PubMed PMID: 24952504.
AÑO: 2014; IF: 20.004
|
24952504
|
Baroja-Mazo A, Barberà-Cremades M, Pelegrín P. The participation of plasma membrane hemichannels to purinergic signaling. Biochim Biophys Acta. 2013 Jan;1828(1):79-93. doi: 10.1016/j.bbamem.2012.01.002. Review. PubMed PMID: 22266266.
AÑO: 2013; IF: 3.431
|
|
Baroja-Mazo A, Barberà-Cremades M, Pelegrín P. P2X7 receptor activation impairs exogenous MHC class I oligopeptides presentation in antigen presenting cells. PLoS One. 2013 Aug 5;8(8):e70577. doi: 10.1371/journal.pone.0070577. PubMed PMID: 23940597; PubMed Central PMCID: PMC3734297.
AÑO: 2013; IF: 3.534
|
|
Garcia-Carmona JA, Almela P, Baroja-Mazo A, Milanes MV, Laorden ML. Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal. Psychopharmacology (Berl). 2012 Mar;220(2):379-93. doi: 10.1007/s00213-011-2478-y. Epub 2011 Sep 21. PubMed PMID: 21947312.
AÑO: 2012; IF: 4.53
|
|
Compan V, Baroja-Mazo A, López-Castejón G, Gomez AI, Martínez CM, Angosto D, Montero MT, Herranz AS, Bazán E, Reimers D, Mulero V, Pelegrín P. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity. 2012 Sep 21;37(3):487-500. doi: 10.1016/j.immuni.2012.06.013. Epub 2012 Sep 13. PubMed PMID: 22981536.
AÑO: 2012; IF: 19.795
|